Sponsor Pipeline

Shanghai Cell Therapy Group Co.,Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
8
Active Trials
8
Recruiting
3
Disease Areas
Active Trials by Phase
Phase 1/2
1
Phase 1
1
Early Phase 1
6
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07146672 Exploratory Study of Super DC Cell Injection in Preventing Recurrence After Radical… Solid Tumor Cancer Recruiting
Phase 1
NCT07479667 An Antibody-armored Dendritic Cell in Patients With Solid Tumors Solid Cancers Recruiting
Early Phase 1
NCT06248697 Exploratory Study of MSLN-CAR T Cells Secreting PD1/CTLA-4 Nanoantibody for the Treatment… Solid Tumor Recruiting
NCT06249256 An Exploratory Study on the Treatment of Advanced Solid Tumors by Fast CAR T Cells Solid Tumor Recruiting
NCT06327997 An Exploratory Study by Fast CAR T Cells Solid Tumor Recruiting
NCT06732232 A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed/ Refractory Multiple… Relapsed Recruiting
NCT06446128 A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed or Refractory B Cell… Non-Hodgkin Lymphoma, B-cell Recruiting
NCT07174843 An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or… Idiopathic Inflammatory Myopathies(IIM) Recruiting
Disease Areas
Get alerts when Shanghai Cell Therapy Group Co.,Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free